Vascular Surgery Aspects in Visceral Surgery - Spectrum, specifics and beneficial potential for the postoperative outcome

• Conditions: OPS 5-524OPS 5-525; T81.0; T81.2; K55.0; K55.1; I72.8; Haemorrhage and haematoma complicating a procedure, not elsewhere classified; Accidental puncture and laceration during a procedure, not elsewhere classified; Acute vascular disorders of intestine; Chronic vascular disorders of intestine

• Registration Number: DRKS00017031
• Lead Sponsor: niversitätsklinik für Allgemein-, Viszeral-, Gefäß- und Transplantationschirurgie

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Completion: 2015-09-01
• Study Start: 2019-06-12
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 113

Inclusion Criteria

Local findings-associated or iatrogenic vascular alteration in the context of surgical or interventional interventions of the visceral-surgical, partly highly specialized surgical profile

- It is a 10-year investigation period (01 January 1999 to 31 December 2008), in which all consecutive adult cases with vascular surgery aspects of visceral surgery were recorded.

Exclusion Criteria

Visceral surgery in the absence of vascular surgery problem constellations

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
- Description of the treatment aspects (resection and revision Op rate, achieved tumor safety margin, R0 resection rate, adjacent body entrainment, blood loss, transfusion requirement, ITS and postoperative treatment duration),<br>- Influence of patient and tumor findings (eg demographic study data such as age, gender, risk factors, preoperative diagnostic profile, hospital and ITS length of stay, TNM classification, vascular infiltration, aging)<br>on postoperative morbidity (rebleeding, anastomotic leakage, thrombosis / embolism, wound abscess, intraabdominal abscess, seroma formation, adrenal gland, pancreatic fistula, residual pancreatitis) and lethality.

Secondary Outcome Measures

Name	Time	Method
Postoperative long-term oncosurgical outcome (5-year survival / tumor recurrence rate / progression-free survival and overall survival)